2013 Education & Advocacy Track


Download a 29-page Preview Guide (pdf) to the 2013 National Rx Drug Abuse Summit.
 

Trends in Rx Drug Abuse
Tuesday, April 2, 2013, 12:30 pm – 1:45 pm
 Moderator Connie M. Payne
Executive Officer, Statewide Services, Kentucky Administrative Office of the Courts, and Board Member, Operation UNITE
 Presenters Tess Benham
Program Manager, National Safety Council
 
 
Hon. Sherry L. Green, JD
Chief Executive Officer, National Alliance for Model State Drug Laws
 
 
Dr. Andrew Kolodny
Chairman, Department of Psychiatry, Maimonides Medical Center
 Session Description Prescription drug abuse is the America’s fastest-growing drug problem according to data from the National Survey on Drug Use and Health. The survey also showed that nearly one-third of people aged 12 and over who used drugs for the first time in 2009 began by using a prescription drug non-medically. Additionally, the latest Monitoring the Future study — the Nation’s largest survey of drug use among young people — showed that prescription drugs are the second most-abused category of drugs after marijuana. With sales of opioid painkillers totaling more than $9 billion a year in IMS Health, marketing of pharmaceuticals has played a fundamental role in this epidemic.

This session will reveal startling facts regarding the scope of the prescription drug problem facing America and provide solutions that can be implanted on a state level. The National Safety Council and National Alliance of Model State Drug Laws (NAMSDL) issued a report in March 2012 that provides a comprehensive comparison of existing state laws and emerging best practices for prescription drug monitoring programs, pain clinic regulations and prescriber education requirements. The presenters will show findings from the report including policy gaps and recommendations for state action.

 Learning Objectives 1. Identify recent increasing trends in the misuse and abuse of prescription drugs.
2. Evaluate the state laws and regulations that exist on a state level across the country.
3. Outline initiatives that can be taken back and implemented in your state.
Enabling & Intervention
Tuesday, April 2, 2013, 2:00 pm – 3:15 pm
 Moderator Regina LaBelle, JD
Chief of Staff, White House Office of National Drug Control Policy
 Presenters Karen Perry
Executive Director, NOPE Task Force
 
 
Dominique Simon-Levine, PhD
Director, Allies in Recovery
 Session Description According to the Centers for Disease Control and Prevention (CDC), 100 people die from drug overdoses every day in the United States; one person every 15 minutes. Family members, neighbors, and friends often struggle with knowing how to help their loved one through a substance abuse addiction. There’s a difficult balance between providing the help they need and further enabling them to continue their behavior.

This session provides two unique and effective approaches for dealing with family members, friends, neighbors, and people in your community who are struggling with substance abuse. Attendees will hear from national experts who come from personal tragedies to provide a beacon of hope for prevention and getting a loved one into treatment.

 Learning Objectives 1. Analyze two effective advocacy programs and the current trends of Rx drug abuse.
2. Describe CRAFT procedures to increase the chance of a loved one entering treatment.
3. Describe the methods for engaging a loved one to seek help.
Youth Programs That Work
Tuesday, April 2, 2013, 3:30 pm – 4:45 pm
 Moderator Karen Perry
Executive Director, NOPE Task Force
 Presenters Arlene Remick
Senior Interactive Communications Manager, IQ Solutions
 
 
Ty Sells
Director of Training and Development, Youth to Youth International
 
 
Nicole Wanty
Research Associate II, KDH Research & Communications
 Session Description According to the Survey of American Attitudes on Substance Abuse, 80 percent of high school students and 44 percent of middle school students see drugs used, kept, sold, and classmates drunk or high on school grounds. The Partnership at Drugfree.org notes that every day 2,500 teens in the United States try prescription drugs to get high for the first time.

Community programs throughout America have shown promise to educate adolescents against the dangerous consequences of prescription drug abuse. Their approaches can be complemented by prevention programs that provide youth with persuasive information about Rx drug abuse to build protective knowledge, attitudes, and skills to avoid such abuse. This session will provide attendees with three strategies to engage America’s youth in prevention and education.

 Learning Objectives 1. Explain program development, and how prevention messages are tailored to the unique characteristics of Rx drug abuse.
2. Explain three Rx drug abuse prevention and education initiatives tailored to youth.
3. Identify strategies that can be used to prevent prescription drug abuse in their home, schools and communities.
Overview of Federal Policies
Wednesday, April 3, 2013, 1:30 pm – 2:45 pm
 Moderator Michael C. Barnes
Attorney, Policy Advisor, DCBA Law & Policy, and Founder and Interim Executive Director, Center for Lawful Access and Abuse Deterrence
 Presenters RADM Dr. Peter Delany, PhD, LCSW-C
Director, Center for Behavioral Health Statistics and Quality
 
 
Diane Luensmann
Director of Communications, The Office of Congressman Nick J. Rahall II
 
Megan O’Donnell
Legislative Director, The Office of Congressman Harold “Hal” Rogers
 Session Description According to the Substance Abuse and Mental Health Services Administration (SAMHSA), more than 650,000 visits to the emergency department in 2010 were due to misuse or abuse of prescription painkillers (about half). Data from the Centers for Disease Control and Prevention (CDC) indicates that unintentional overdose deaths involving opiate analgesics now exceed deaths from cocaine and heroin combined. Motor vehicle traffic deaths have been surpassed by drug poisoning deaths almost everywhere in the United States. No community is immune from the rampant growth of prescription drug abuse. Reactions to the root causes and direct impacts of abuse – whether through prevention, treatment or education initiatives – are varied.

This session begins with an overview of latest results from the several national data systems including the National Survey on Drug Use and Health (NSDUH), which includes national and state-level data on the non-medical use of prescription drugs; the Drug Abuse Warning Network (DAWN), which includes information on emergency department (ED) visits resulting from substance use, misuse and adverse actions to drugs; and the Treatment Episode Data Set (TEDS), which provides information on characteristics of individuals admitted for substance abuse treatment.

During an interactive session that follows, attendees will be able to ask questions of staff members of The Congress of the United States as a follow-up to the Congressional panel from the morning’s General Session. The presenters will provide an overview of the many federal policies that have been implemented or are currently being debated in Congress. The presenters will also discuss strategies to engage their Member of Congress in this issue, as well as the Member’s staff.

 Learning Objectives 1. Analyze current legislation being debated in Congress relating to prescription drug abuse.
2. Describe recent legislation Congress has enacted and its impact.
3. Identify resources to advocate for change, with specific focus on federal policies.
Reducing Rx Abuse at the Community Level: A Comprehensive Coalition Approach
Wednesday, April 3, 2013, 3:00 pm – 4:15 pm
 Moderator Connie M. Payne
Executive Officer, Statewide Services, Kentucky Administrative Office of the Courts, and Board Member, Operation UNITE
 Presenters Mary E. Elliott
Vice President, Communications, Membership and IT, Community Anti-Drug Coalitions of America
 
Craig L. PoVey, MSW
State of Utah Administrator, SAMHSA, and Chair, Utah Prevention Advisory Council
 Session Description In 2010, 2 million people reported using prescription painkillers non-medically for the first time within the last year — nearly 5,500 a day according to SAMHSA. According to the 2008 Behavioral Risk Factor Surveillance System (BRFSS), 90 percent of Utah residents reported obtaining a prescription pain medication, without a doctor’s permission, from a friend or family member.

In this session, participants will examine the unique characteristics of prescription drug abuse and offer multiple strategies for developing a comprehensive approach to target an array of local conditions. Presenters will provide specifics about how their programs educate providers, patients, and the public to recognize and prevent pain medication-related harms. There will also be recommendations for utilizing the state prescription drug monitoring programs (PDMPs) to identify risk factors for prescription pain medication overdose to potentially prevent deaths, and create medical treatment and quality care guidelines on prescribing opioids.

 Learning Objectives 1. Describe how coalitions can identify specific conditions in their communities.
2. Prepare comprehensive, evidence-based strategies to address the local conditions.
3. Demonstrate coalition capacity to prevent Rx drug abuse in their communities.